AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMOXICILLIN AND CLAVULANATE POTASSIUM

32 registrations across 5 African markets— 24 active

Markets with AMOXICILLIN AND CLAVULANATE POTASSIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
CLAVAS 625 TABLETS (​Each tablet contains​ ​Amoxicillin and Clavulanate Potassium​ ​625mg​)🇬🇭GhanaactiveJul 2031
CLAVAS 457 SUSPENSION (Each 5ml contains Amoxicillin and Clavulanate Potassium 457mg)🇬🇭GhanaactiveJul 2031
CLAVAS 228 SUSPENSION (Each 5ml contains Amoxicillin and Clavulanate Potassium 228mg)🇬🇭GhanaactiveJul 2031
CO-AMOXICLAV 228.5 Suspension (Each 5ml of reconstituted suspension contains Amoxicillin and Clavulanate Potassium 200mg/28.5mg)🇬🇭GhanaactiveMay 2031
CO-AMOXICLAV 457 TABLETS Suspension (Each 5ml of reconstituted suspension contains Amoxicillin and Clavulanate Potassium 400mg/57mg)🇬🇭GhanaactiveMay 2031
CO-AMOXICLAV 457 TABLETS Suspension (Each 5ml of reconstituted suspension contains Amoxicillin and Clavulanate Potassium 400mg/57mg)🇬🇭GhanaactiveMay 2031
CO-AMOXICLAV 228.5 Suspension (Each 5ml of reconstituted suspension contains Amoxicillin and Clavulanate Potassium 200mg/28.5mg)🇬🇭GhanaactiveMay 2031
AC-CLAV 1000 TABLETS (Each film coated tablet contains Amoxicillin and Cluvalanate Potassium 1000mg🇬🇭GhanaactiveDec 2030
AC-CLAV 1000 TABLETS (Each film coated tablet contains Amoxicillin and Cluvalanate Potassium 1000mg🇬🇭GhanaactiveDec 2030
AMOXICILLIN AND CLAVULANATE POTASSIUM
TABLETS
🇷🇼RwandaREYOUNG PHARMACEUTICAL CO., LTDactiveOct 2029
CLAVICIN ORAL SUSPENSION🇬🇭GhanaactiveFeb 2029
CLAVULIN POWDER SUSPENSION🇬🇭GhanaactiveFeb 2029
CLAVICIN ORAL SUSPENSION🇬🇭GhanaactiveFeb 2029
CLAVULIN POWDER SUSPENSION🇬🇭GhanaactiveFeb 2029
CLAVICIN XR TABLETS🇬🇭GhanaactiveJan 2029
CLAVICIN XR TABLETS🇬🇭GhanaactiveJan 2029
AGELAMATE TABLETS
Tablet
🇰🇪KenyaMEDCURE HEALTHCAREactiveNov 2027
SPOTCLAV 625
Tablet
🇰🇪KenyaSPARSH BIO-TECH PRIVATE LIMITactiveJun 2026
AMOXICILLIN_&CLAVULANATE_POTASSIUM 625MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
ACINET_1000 875/125MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
ALPHACLAV_1.2G 1.2G INJECTION
INJECTION
🇲🇼MalawiexpiredMar 2024
ALPHACLAV_625 625MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
MACLAV_625 625MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
GAMOK 875/125MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2022
GAMOK 250/125MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2021
CLAMOXIN_457 457MG POWDER FOR ORAL SUSPENSION
POWDER FOR ORAL SUSPENSION
🇲🇼MalawiexpiredJun 2018
AKUCLAV
Powder for solution for injection
🇹🇿TanzaniaNORTH CHINA PHARMACEUTICAL CO. LTDactive
Clavugen
Powder for Injection
🇹🇿TanzaniaGENERICS & SPECIALITIES LTDactive
ALPHACLAV DS-228.5
Powder for Oral suspension
🇹🇿TanzaniaNeomedic Limitedactive
Rapiclav 250 DT
Tablets
🇹🇿TanzaniaIPCA Laboratories Limitedactive
Redmentin DS
Suspension, Oral
🇹🇿TanzaniaNeomi Pharmaceuticals Pvt. Ltdactive
Spotclav 625
Tablets
🇹🇿TanzaniaSparsh Bio-tech Private Limitedactive

AMOXICILLIN AND CLAVULANATE POTASSIUM in Africa — Regulatory Overview

AMOXICILLIN AND CLAVULANATE POTASSIUM is registered across 5 African markets with 32 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Tanzania, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 32 registrations, 24 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.